Reported Dec 14, 2022 · Terminated

Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC

RemedyRepack Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: RemedyRepack Inc. · 625 Kolter Dr Ste 4 · Indiana, PA · 15701-3571

Is this the product you have?

Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC

3 of 3 products

Products covered by this recall
#Product as published
123155-0490-01
2MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816
3Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.
Lot codes and dates
    • Lot # B1817019-082222
    • Exp. 02/24/2023
    • B1819127-082322
    • Exp. 02/26/2023
Amount recalled
9 boxes

Where it was sold

Why it was recalled

Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new RemedyRepack Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Feb 3, 2023 · Data as of Sep 19, 8:38 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.